CRISPR Therapeutics (CRSP) PT Raised to $84 at Needham & Company

November 19, 2019 11:32 AM EST Send to a Friend

Needham & Company analyst Alan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CRISPR Therapeutics (CRSP) PT Raised to $84 at Needham & Company

Member Login

Free News Feed